Chapter 12. Role of Autologous BMT in Children with Acute Myeloid Leukemia in First Remission

  1. Ross Pinkerton1,
  2. Katherine Matthay3,
  3. AG Shankar2 and
  4. Katherine Matthay3

Published Online: 4 OCT 2007

DOI: 10.1002/9780470987148.ch12

Evidence-based Pediatric Oncology, Second Edition

Evidence-based Pediatric Oncology, Second Edition

How to Cite

Pinkerton, R., Matthay, K., Shankar, A. and Matthay, K. (eds) (2007) Role of Autologous BMT in Children with Acute Myeloid Leukemia in First Remission, in Evidence-based Pediatric Oncology, Second Edition, Blackwell Publishing, Oxford, UK. doi: 10.1002/9780470987148.ch12

Editor Information

  1. 1

    Childrens Cancer Unit, Mater Childrens Hospital, Raymond Terrace, Brisbane, Australia

  2. 2

    Department of Paediatric and Adolescent Oncology, University College of London NHS Trust, London, UK

  3. 3

    Department of Pediatric Oncology, University of California at San Francisco, San Francisco, CA, USA

Publication History

  1. Published Online: 4 OCT 2007
  2. Published Print: 13 APR 2007

ISBN Information

Print ISBN: 9781405142687

Online ISBN: 9780470987148

SEARCH

Keywords:

  • acute myeloid leukemia (AML);
  • induction therapy;
  • leukemia relapse;
  • cytosine arabinoside;
  • toxicity

Summary

This chapter contains sections titled:

  • Study 1

  • Study 2

  • Study 3

  • Study 4